Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Greater Cannabis Company (GCAN) Cash & Current Investments (2017 - 2026)

Greater Cannabis Company has reported Cash & Current Investments over the past 6 years, most recently at $270030.0 for Q4 2022.

  • For Q4 2022, Cash & Current Investments fell 28.47% year-over-year to $270030.0; the TTM value through Dec 2022 reached $270030.0, down 28.47%, while the annual FY2022 figure was $270030.0, 28.47% down from the prior year.
  • Cash & Current Investments for Q4 2022 was $270030.0 at Greater Cannabis Company, down from $311197.0 in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $528930.0 in Q2 2021 and troughed at $24662.0 in Q4 2019.
  • A 5-year average of $212913.5 and a median of $178632.0 in 2020 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 10466.4% in 2018 and later tumbled 58.82% in 2019.
  • Year by year, Cash & Current Investments stood at $59891.0 in 2018, then tumbled by 58.82% to $24662.0 in 2019, then surged by 358.0% to $112953.0 in 2020, then soared by 234.23% to $377520.0 in 2021, then fell by 28.47% to $270030.0 in 2022.
  • Business Quant data shows Cash & Current Investments for GCAN at $270030.0 in Q4 2022, $311197.0 in Q2 2022, and $377520.0 in Q4 2021.